drugset / Trial / NCT00016055

Biological Therapy and Temozolomide in Treating Patients With Metastatic Melanoma

NCT00016055

Phase 1 Unknown 18 enrolled St. Luke's Medical Center
Treatment

Summary

RATIONALE: Biological therapies use different ways to stimulate the immune system and stop cancer cells from growing. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining biological therapy with chemotherapy may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of biological therapy combined with temozolomide in treating patients who have metastatic melanoma.

Timeline

Start
2000-11
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject 12ATC Cell therapy Intravenous
Subject Temozolomide Small molecule Oral

Indications